![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | multiple interactions | ISO | RGD:1319048 | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of EFS mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | affects expression | ISO | RGD:1319048 | 6480464 | 1, 2-Dimethylhydrazine affects the expression of EFS mRNA | CTD | PMID:22206623 | 1-naphthyl isothiocyanate | increases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in increased expression of EFS mRNA | CTD | PMID:30723492 | 17alpha-ethynylestradiol | affects expression | ISO | RGD:1319048 | 6480464 | Ethinyl Estradiol affects the expression of EFS mRNA | CTD | PMID:17555576 | 17alpha-ethynylestradiol | decreases expression | EXP | | 6480464 | Ethinyl Estradiol results in decreased expression of EFS mRNA | CTD | PMID:17557909 | 17beta-estradiol | multiple interactions | ISO | RGD:1319047 | 6480464 | [Progesterone co-treated with Estradiol] results in decreased expression of EFS mRNA | CTD | PMID:17404688 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1319048 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of EFS mRNA | CTD | PMID:21354282 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of EFS mRNA | CTD | PMID:32109520 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:1319047 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of EFS mRNA | CTD | PMID:28628672 | 4-hydroxyphenyl retinamide | decreases expression | ISO | RGD:1319048 | 6480464 | Fenretinide results in decreased expression of EFS mRNA | CTD | PMID:28973697 | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of EFS mRNA | CTD | PMID:24780913 | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of EFS mRNA | CTD | PMID:31881176 | all-trans-retinoic acid | decreases expression | ISO | RGD:1319047 | 6480464 | Tretinoin results in decreased expression of EFS mRNA | CTD | PMID:21934132 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of EFS mRNA | CTD | PMID:16483693 | amphetamine | increases expression | EXP | | 6480464 | Amphetamine results in increased expression of EFS mRNA | CTD | PMID:30779732 | antirheumatic drug | increases expression | ISO | RGD:1319047 | 6480464 | Antirheumatic Agents results in increased expression of EFS mRNA | CTD | PMID:24449571 | arsane | multiple interactions | ISO | RGD:1319047 | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of EFS mRNA | CTD | PMID:32525701 | arsenic atom | multiple interactions | ISO | RGD:1319047 | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of EFS mRNA | CTD | PMID:32525701 | benzo[a]pyrene | decreases methylation | ISO | RGD:1319047 | 6480464 | Benzoapyrene results in decreased methylation of EFS exon, Benzoapyrene results in decreased methylation of EFS promoter | CTD | PMID:27901495 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of EFS mRNA | CTD | PMID:25181051 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of EFS mRNA | CTD | PMID:30816183 | bisphenol A | multiple interactions | ISO | RGD:1319047 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of EFS mRNA | CTD | PMID:28628672 | carbamazepine | affects expression | ISO | RGD:1319047 | 6480464 | Carbamazepine affects the expression of EFS mRNA | CTD | PMID:25979313 | carbon nanotube | increases expression | ISO | RGD:1319048 | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | chrysene | increases expression | ISO | RGD:1319048 | 6480464 | chrysene results in increased expression of EFS mRNA | CTD | PMID:26377693 | clothianidin | decreases expression | ISO | RGD:1319047 | 6480464 | clothianidin results in decreased expression of EFS mRNA | CTD | PMID:31626844 | dexamethasone | multiple interactions | ISO | RGD:1319047 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of EFS mRNA | CTD | PMID:28628672 | dibutyl phthalate | increases expression | ISO | RGD:1319048 | 6480464 | Dibutyl Phthalate results in increased expression of EFS mRNA | CTD | PMID:17361019, PMID:21266533 | dorsomorphin | multiple interactions | ISO | RGD:1319047 | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... | CTD | PMID:27188386 | ethanol | increases expression | ISO | RGD:1319048 | 6480464 | Ethanol results in increased expression of EFS mRNA | CTD | PMID:30319688 | etoposide | increases expression | ISO | RGD:1319048 | 6480464 | Etoposide results in increased expression of EFS mRNA | CTD | PMID:25270620 | folic acid | multiple interactions | ISO | RGD:1319048 | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of EFS mRNA | CTD | PMID:22206623 | formaldehyde | increases expression | ISO | RGD:1319047 | 6480464 | Formaldehyde results in increased expression of EFS mRNA | CTD | PMID:27905399 | furan | increases expression | EXP | | 6480464 | furan results in increased expression of EFS mRNA | CTD | PMID:27387713 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of EFS mRNA | CTD | PMID:22061828 | hydroquinone O-beta-D-glucopyranoside | decreases expression | ISO | RGD:1319047 | 6480464 | Arbutin results in decreased expression of EFS mRNA | CTD | PMID:17103032 | indometacin | multiple interactions | ISO | RGD:1319047 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of EFS mRNA | CTD | PMID:28628672 | mitomycin C | increases expression | ISO | RGD:1319048 | 6480464 | Mitomycin results in increased expression of EFS mRNA | CTD | PMID:25270620 | N-methyl-N-nitrosourea | increases expression | ISO | RGD:1319048 | 6480464 | Methylnitrosourea results in increased expression of EFS mRNA | CTD | PMID:25270620 | PCB138 | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:23829299 | phenylmercury acetate | decreases expression | ISO | RGD:1319047 | 6480464 | Phenylmercuric Acetate results in decreased expression of EFS mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | RGD:1319047 | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of EFS mRNA | CTD | PMID:27188386 | progesterone | multiple interactions | ISO | RGD:1319047 | 6480464 | [Progesterone co-treated with Estradiol] results in decreased expression of EFS mRNA | CTD | PMID:17404688 | propionic acid | decreases expression | ISO | RGD:1319047 | 6480464 | propionic acid results in decreased expression of EFS mRNA | CTD | PMID:31526819 | SB 431542 | multiple interactions | ISO | RGD:1319047 | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... | CTD | PMID:27188386 | sodium arsenate | multiple interactions | ISO | RGD:1319047 | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of EFS mRNA | CTD | PMID:32525701 | sunitinib | decreases expression | ISO | RGD:1319047 | 6480464 | Sunitinib results in decreased expression of EFS mRNA | CTD | PMID:31533062 | tert-butyl hydroperoxide | increases expression | ISO | RGD:1319047 | 6480464 | tert-Butylhydroperoxide results in increased expression of EFS mRNA | CTD | PMID:15336504 | titanium dioxide | increases expression | ISO | RGD:1319048 | 6480464 | titanium dioxide results in increased expression of EFS mRNA | CTD | PMID:23557971 | trimellitic anhydride | decreases expression | ISO | RGD:1319048 | 6480464 | trimellitic anhydride results in decreased expression of EFS mRNA | CTD | PMID:19042947 | tunicamycin | decreases expression | ISO | RGD:1319047 | 6480464 | Tunicamycin results in decreased expression of EFS mRNA | CTD | PMID:22378314 | valproic acid | decreases expression | ISO | RGD:1319048 | 6480464 | Valproic Acid results in decreased expression of EFS mRNA | CTD | PMID:19136453 more ... | valproic acid | increases methylation | ISO | RGD:1319047 | 6480464 | Valproic Acid results in increased methylation of EFS gene | CTD | PMID:29154799 | valproic acid | affects expression | ISO | RGD:1319047 | 6480464 | Valproic Acid affects the expression of EFS mRNA | CTD | PMID:25979313 | valproic acid | decreases expression | ISO | RGD:1319047 | 6480464 | Valproic Acid results in decreased expression of EFS mRNA | CTD | PMID:19101580 more ... | valproic acid | multiple interactions | ISO | RGD:1319047 | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of EFS mRNA | CTD | PMID:27188386 | WIN 55212-2 | decreases expression | ISO | RGD:1319048 | 6480464 | 3R-2 more ... | CTD | PMID:12237329 | |